0001127602-20-015658.txt : 20200506 0001127602-20-015658.hdr.sgml : 20200506 20200506171745 ACCESSION NUMBER: 0001127602-20-015658 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200504 FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clyburn Frank CENTRAL INDEX KEY: 0001763963 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 20853651 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-05-04 0000310158 Merck & Co., Inc. MRK 0001763963 Clyburn Frank MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 1 EVP, Chief Commercial Officer Common Stock 2020-05-04 4 M 0 1904 77.67 A 79797.106 D Common Stock 2020-05-04 4 F 0 938 77.67 D 78859.106 D Common Stock 2020-05-05 4 M 0 3752 76.86 A 82611.106 D Common Stock 2020-05-05 4 F 0 1848 76.86 D 80763.106 D Common Stock - 401(k) Plan 1617.0982 I By 401(k) Restricted Stock Unit 2020-05-04 4 M 0 1904 0 D 2019-05-04 2021-05-04 Common Stock 1904 1906 D Restricted Stock Unit 2020-05-05 4 M 0 3752 0 D 2020-05-05 2020-05-05 Common Stock 3752 0 D Holdings include shares acquired in dividend reinvestment transactions. Includes shares acquired and dividends earned through April 7, 2020, in the Merck U.S. Savings Plan, a 401(k) plan. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. /s/ Faye C. Brown as Attorney-in-Fact for Frank Clyburn 2020-05-06